InvestorsHub Logo
Followers 42
Posts 4626
Boards Moderated 0
Alias Born 05/10/2013

Re: None

Wednesday, 08/11/2021 9:17:09 PM

Wednesday, August 11, 2021 9:17:09 PM

Post# of 233271
Whewwwww boy, Nader caught lying again. Page 7. Kelly and Nader requested that Patterson and Beaty submit a proposed to Cytodyn for the terms it would be willing to sell incelldx… Nader just burned himself again.

Dr. Pourhassan and Dr. Scott Kelly requested that Dr. Patterson and Mr. Beaty submit a proposal to the Company stating the terms by which IncellDx may be willing to be sold to the Company. IncellDx’s financial advisor, Moelis & Company, prepared a PowerPoint setting forth a preliminary proposal, which Dr. Patterson forwarded to the Company as the Company had requested, and no further discussions ensued. Given the perfunctory and short-lived nature of the discussions, they are not required to be disclosed in a proxy statement. Consistent with Item 404 of Regulation S-K, we do not consider this to be a material omission because there was no transaction to describe. There are no conflicts of interest with respect to Dr. Patterson that are required to be disclosed that have not been so disclosed.
Contrary to your assertion, Dr. Patterson has not attempted to patent certain uses of the Company’s drug candidate, Leronlimab, as his own. Any patent applications submitted in connection with certain uses of CCR5 antagonists in COVID-19 have been submitted by IncellDx, not Dr. Patterson. Regardless, those patents are currently pending and have not been rejected and do not directly conflict with patents held solely by the Company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News